GHK-Cu vs Tesamorelin
A comprehensive, data-driven comparison of GHK-Cu (Copper Peptide) and Tesamorelin (Egrifta). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | GHK-Cu Copper Peptide, GHK-Copper | Tesamorelin Egrifta, TH9507 |
|---|---|---|
| FDA Status | Not submitted | FDA Approved |
| Category | Anti-Aging | Growth Hormone |
| Primary Use | Skin rejuvenation and anti-aging | HIV-associated lipodystrophy |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $30 - $150/mo | $200 - $1,500/mo |
| Administration | Topical | Subcutaneous injection |
| Typical Dose | 1-2% topical cream daily, or 1-2mg injection | 2mg daily |
| Frequency | Daily | Daily |
| Mechanism | Naturally occurring copper complex that stimulates collagen production, promotes tissue remodeling, and has antioxidant properties | Synthetic GHRH analog that reduces visceral adipose tissue by stimulating growth hormone production |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Moderate | High |
| Clinical Trial Phase | N/A | Approved |
Key Differences
- 1Tesamorelin is FDA-approved, while GHK-Cu is currently not submitted.
- 2GHK-Cu is generally more affordable ($30 - $150/mo) compared to Tesamorelin ($200 - $1,500/mo).
- 3GHK-Cu is administered via topical, while Tesamorelin uses subcutaneous injection.
- 4Tesamorelin has high-quality evidence, while GHK-Cu has moderate-quality evidence.
- 5They belong to different categories: GHK-Cu (Anti-Aging) vs Tesamorelin (Growth Hormone).
Which Is Better For...
Tesamorelin
Those seeking an FDA-approved treatment with established safety data
GHK-Cu
More budget-friendly option with lower monthly costs
GHK-Cu
Fewer commonly reported side effects
Tesamorelin
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| GHK-Cu | $30 - $150/mo | Not submitted | Various research labs |
| Tesamorelin | $200 - $1,500/mo | FDA Approved | Theratechnologies |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
GHK-Cu works via Naturally occurring copper complex that stimulates collagen production, promotes tissue remodeling, and. Tesamorelin works via Synthetic GHRH analog that reduces visceral adipose tissue by stimulating growth hormone. They differ in FDA approval status, efficacy data, and cost.
GHK-Cu typically costs $30 - $150/mo, while Tesamorelin costs $200 - $1,500/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
GHK-Cu is not FDA-approved (Not submitted). Tesamorelin is FDA-approved. FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of GHK-Cu include Mild skin irritation (topical), Injection site reactions, Temporary copper taste. Common side effects of Tesamorelin include Injection site reactions, Arthralgia, Peripheral edema. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
GHK-Cu is a naturally occurring copper-binding peptide found in human plasma that declines with age. It has been extensively studied for skin rejuvenation due to its ability to stimulate collagen and ...
View Full GHK-Cu GuideTesamorelin is an FDA-approved synthetic growth hormone releasing hormone analog specifically indicated for reducing excess abdominal fat in HIV-infected patients with lipodystrophy. A new weekly reco...
View Full Tesamorelin GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between GHK-Cu and Tesamorelin should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.